Drug makers object to U.S. plan for early warnings

WASHINGTON (Reuters) - Plans by U.S. regulators to release preliminary information about potential drug side effects could lead to unnecessary confusion and "irrational fears" about medicines, drug makers said.

Continue to Drug makers object to U.S. plan for early warnings on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz